Awareness News

  • Lars Østergaard, MD, PhD, of the clinical medicine and infectious diseases departments of Aarhus University Hospital in Denmark, and colleagues reported in The New England Journal of Medicine  trial studies on Trumenba, a bivalent meningococcal B vaccine.

    Continue reading